Jim, There is more, even if you don't believe the Prion argument.....try PAH (Pulmonary Hypertension)
[
link to www.ncbi.nlm.nih.gov (secure)]
Pulmonary HypertensionPAH is a serious disease without a cure that can affect males and females of any age including children. The increased pulmonary vascular resistance in
PAH results in right heart failure and subsequently death. Patients diagnosed with PAH only live for 2–3 years from the time of diagnosis on average if untreated [30,31]. Even with currently available therapies, only 60–70% of PAH patients survive for three years
SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Cells It was found that the treatment of cultured primary human pulmonary artery smooth muscle cells (SMCs) or human pulmonary artery endothelial cells with
the recombinant SARS-CoV-2 spike protein S1 subunit is sufficient to promote cell signaling without the rest of the viral components [21]. Furthermore, our analysis of the postmortem lung tissues of patients who died of COVID-19 has determined that these patients
exhibited pulmonary vascular wall thickening, a hallmark of pulmonary arterial hypertension (PAH) [21]. Based on these results, we proposed that
the SARS-CoV-2 spike protein (without the rest of the viral components) triggers cell signaling events that may promote pulmonary vascular remodeling and PAH as well as possibly other cardiovascular complications.